Construction and Identification of Recombinant Adenovirus Containing Human p27 Gene
Wu Ke
Abstract
Wu Ke
Abstract
Objective:To construct and identify the recombinant adenovirus plasmid containing exogenous p27 gene and EGFP gene and to detect the gene expression.Methods: Genetic engineering techniques,including plasmid extraction,agarose gel electrophoresis,restriction enzymolysis,connection,transformation of competent cells,were used to construct the recombinant plasmid of pCMV-IRES2-EGFP-p27.The adenovirus plasmid pAdeno-CMV-p27-EGFP was constructed by adeno-x expression system.The plasmids were identified by enzymolysis and PCR.Recombinant adenovirus vector was packaged by cell line 293.The expression of EGFP was detected under the fluorescence microscopy.Results: pCMV-IRES2-EGFP-p27 was successfully constructed and identified by enzymolysis and sequencing.Fluorescence microscopy revealed that the expression of EGFP could be detected at 48th h after the plasmid was transfected into astrocytes,and the expression of EGFP was increased to the peak at 48-72 h.The adenovirus plasmids pAdeno-CMV-p27-EGFP was successfully constructed and identified by enzymolysis and PCR.The CPE and the expression of EGFP could be observed after the plasmid pAdeno-CMV-p27-EGFP was transfected.Conclusion: The adenovirus plasmid containing human p27 gene was constructed successfully by adeno-X system.It will establish a foundation for the future research about the relationship of chronic graft dysfunction and immunological tolerance.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To construct and identify the recombinant adenovirus plasmid containing exogenous p27 gene and EGFP gene and to detect the gene expression.Methods: Genetic engineering techniques,including plasmid extraction,agarose gel electrophoresis,restriction enzymolysis,connection,transformation of competent cells,were used to construct the recombinant plasmid of pCMV-IRES2-EGFP-p27.The adenovirus plasmid pAdeno-CMV-p27-EGFP was constructed by adeno-x expression system.The plasmids were identified by enzymolysis and PCR.Recombinant adenovirus vector was packaged by cell line 293.The expression of EGFP was detected under the fluorescence microscopy.Results: pCMV-IRES2-EGFP-p27 was successfully constructed and identified by enzymolysis and sequencing.Fluorescence microscopy revealed that the expression of EGFP could be detected at 48th h after the plasmid was transfected into astrocytes,and the expression of EGFP was increased to the peak at 48-72 h.The adenovirus plasmids pAdeno-CMV-p27-EGFP was successfully constructed and identified by enzymolysis and PCR.The CPE and the expression of EGFP could be observed after the plasmid pAdeno-CMV-p27-EGFP was transfected.Conclusion: The adenovirus plasmid containing human p27 gene was constructed successfully by adeno-X system.It will establish a foundation for the future research about the relationship of chronic graft dysfunction and immunological tolerance.
Key concepts: Plasmid, Recombinant DNA, Molecular biology, Agarose gel electrophoresis, Green fluorescent protein, Transfection, Biology, Transformation (genetics)